Chronic Progesterone Treatment Augments While Dehydroepiandrosterone Sulphate Prevents Tolerance to Ethanol Anxiolysis and Withdrawal Anxiety in Rats

    Ajaykumar N. Sharma, Chandrabhan T. Chopde, Khemraj Hirani, Dadasaheb M. Kokare, Rajesh R. Ugale
    TLDR Progesterone increases alcohol tolerance and withdrawal anxiety, while DHEAS prevents them.
    The study investigated the effects of neurosteroids on ethanol-induced anxiolysis and withdrawal anxiety in rats. It found that chronic progesterone treatment, which increases levels of the neurosteroid allopregnanolone, augmented the development of tolerance to the anxiolytic effects of ethanol and withdrawal anxiety. In contrast, dehydroepiandrosterone sulphate (DHEAS), a negative modulator of GABAA receptors, and finasteride, which inhibits the conversion of progesterone to allopregnanolone, prevented these effects. The research highlighted the differential roles of GABAergic neurosteroids in ethanol tolerance and dependence, suggesting potential therapeutic targets for managing alcohol-related anxiety disorders.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 179 results

    Related Research

    2 / 2 results